Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18280898 | 1.00 | KDM1A (0.33) | KDM1A | |
| SCHEMBL2264806 | 0.79 | — | — | |
| SCHEMBL2264803 | 0.79 | — | — | |
| SCHEMBL11071002 | 0.79 | KDM1A (0.35) | KDM1A | |
| SCHEMBL31290727 | 0.79 | — | — | |
| SCHEMBL11071014 | 0.79 | KDM1A (0.35) | KDM1A | |
| SCHEMBL28100320 | 0.78 | TLR4 (0.34) | — | |
| SCHEMBL28100321 | 0.78 | TLR4 (0.34) | — | |
| SCHEMBL15775089 | 0.77 | — | — | |
| SCHEMBL235344 | 0.73 | KDM1A (0.48) | KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250214920-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | KAO CORPORATION (JP) | 2025-07-03 | — | — | US | claimed |
| US-20250214921-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | KAO CORPORATION (JP) | 2025-07-03 | — | — | US | claimed |
| EP-4501896-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | Kao Corporation (JP) | 2025-02-05 | — | — | EP | claimed |
| EP-4501897-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | Kao Corporation (JP) | 2025-02-05 | — | — | EP | claimed |
| CN-118973991-A | Process for producing cyclic diketone compound | 花王株式会社 | 2024-11-15 | — | — | CN | claimed |
| CN-118973990-A | Process for producing cyclic diketone compound | 花王株式会社 | 2024-11-15 | — | — | CN | claimed |
| WO-2023189722-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | 花王株式会社 | 2023-10-05 | — | — | WO | claimed |
| WO-2023189723-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | 花王株式会社 | 2023-10-05 | — | — | WO | claimed |
| CN-107709283-B | Process for preparing 3-methylcyclopentadecane-1, 5-dione | 巴斯夫欧洲公司 | 2021-02-02 | — | — | CN | claimed |
| US-20250214920-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | KAO CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| US-20250214921-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | KAO CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| EP-4501896-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | Kao Corporation (JP) | 2025-02-05 | — | — | EP | disclosed |
| EP-4501897-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | Kao Corporation (JP) | 2025-02-05 | — | — | EP | disclosed |
| CN-118973991-A | Process for producing cyclic diketone compound | 花王株式会社 | 2024-11-15 | — | — | CN | disclosed |
| WO-2023189722-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | 花王株式会社 | 2023-10-05 | — | — | WO | disclosed |
| US-20220119404-A1 | METHOD FOR PRODUCING CYCLIC ENOL ETHER COMPOUND | KAO CORPORATION (JP) | 2022-04-21 | — | — | US | disclosed |
| CN-112771051-B | Method for producing cyclic enol ether compound | 花王株式会社 | 2022-04-05 | — | — | CN | disclosed |
| EP-3862356-A1 | METHOD FOR PRODUCING CYCLIC ENOL ETHER COMPOUND | Kao Corporation (JP) | 2021-08-11 | — | — | EP | disclosed |
| EP-3303278-A1 | PROCESS FOR PREPARING 3-METHYLCYCLOPENTADECANE-1,5-DIONE | BASF SE (DE) | 2018-04-11 | — | — | EP | disclosed |
| WO-2016193330-A1 | PROCESS FOR PREPARING 3-METHYLCYCLOPENTADECANE-1,5-DIONE | BASF SE (DE) | 2016-12-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250214920-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | CYP4F2, DUOX1, BCKDK | KDM1A 2384/4885 |
| US-20220119404-A1 | METHOD FOR PRODUCING CYCLIC ENOL ETHER COMPOUND | ERG28, ADH1A, SQLE | KDM1A 1886/4885 |
| US-20250214921-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | HSD17B7, HSD17B12, BCKDK | KDM1A 3537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.